Russell Abberley

Russell Abberley has been the General Manager of Amgen UK & Ireland since May 2020.

Russell has over 25 years of life science industry leadership expertise across a range of geographies and covering country, regional and global roles. His expertise spans all stages of the product life cycle and he has worked across multiple therapy areas on originator medicines and biosimilars in commercial and operational roles at companies including AstraZeneca, MSD and Schering Plough.

Russell has served on the Association of the British Pharmaceuticals Industry (ABPI) Board since July 2020, chairing both the Clinical Trials Board Sponsored Group (BSG) along with the Commercial and VPAG BSG. He is a member of the Governance Committee and was part of the Negotiating Team for the recently signed 2024 VPAG scheme.

Russell is a member of the American Pharmaceutical Group and served as Chair from August 2021 to October 2023.

Russell became the Vice President of the ABPI on 16 May, and Acting President on 4 September 2024.